Inflammatory Bowel Disease and Immunoglobulin Patterns
Diagnostic Biomarkers
- Fecal calprotectin is the preferred biomarker for monitoring inflammation in IBD patients, with levels <50 μg/g reassuring for ruling out active inflammation, according to the American Gastroenterological Association 1, 2
- Values between 50-250 μg/g require further evaluation as they may indicate low-grade inflammation, with the American Gastroenterological Association recommending further testing in such cases 1, 2
- Serial monitoring of fecal calprotectin at 3-6 month intervals facilitates early recognition of disease flares in IBD patients, as suggested by the Clinical Gastroenterology and Hepatology guidelines 1, 2